SGH
ARNA

Schonfeld Group Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Schonfeld Group Holdings’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,057
Closed -$67K – 379
2014
Q1 		$67K Sell
1,057
-369
-26% -$24.5K 0.02% 512
2013
Q4 		$83K Buy
1,426
+286
+25% +$14.9K 0.03% 367
2013
Q3 		$60K Buy
+1,140
New +$76.5K 0.12% 117

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schonfeld Group Holdings's ARNA Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2014, closing a stake of 1,057 shares — an estimated $67K sold.

Schonfeld Group Holdings first reported a position in ARNA in Q3 2013 and held it in 3 quarters. The position peaked at $83K in Q4 2013. 129 funds tracked by Wall St. Rank hold ARNA as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining Arena Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 1,057 Arena Pharmaceuticals Inc shares in Q2 2014, an estimated $67K.
  • Schonfeld Group Holdings first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
  • Schonfeld Group Holdings's Arena Pharmaceuticals Inc position peaked at $83K in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.